Meaningful Disease Burden Measurements in Patients With Psoriasis
Bruce Strober, MD, PhD, published a paper recently in JAMA Dermatol focusing on disease burden measurements of meaning to patients with psoriasis.
Read More
Author: Teresa Sellinger
IL-23 p19 Inhibitors Safe for Moderate-to-Severe Plaque Psoriasis
At Maui Derm Hawaii, Andrew Blauvelt, MD, MBA, presented as part of “Psoriasis Update: 2024.” Here, we summarize a paper he published in this area of study.
Read More
Psoriatic Disease Management Suboptimal
At Maui Derm Hawaii, held January 22-26, 2024, Linda Stein-Gold, MD, presented as part of “Challenging Cases in Psoriasis.”
Read More
Catching People Doing the Right Thing: The Overlooked Art of Positive Feedback
We can be so focused on what has gone wrong with a project, system, or endeavor that we forget to see what is going right.
Read More
Medical Fiction: The Gatekeeper of Life
In this medical fiction, Max wields his stamp with zeal, evaluating prior authorizations by cost rather than quality, as Silvia’s symptoms force her to navigate the same greedy system.
Read More
Examining Disparities in the Management of NSCLC
2023 NACLC Opening Keynote Speaker Marjory Charlot, MD, MPH, MSc, presented “Equities and Disparities,” focusing on disparities in the management of NSCLC.
Read More
Social Determinants of Health Influence Survival in NSCLC
Social determinants of health influenced the achievement of textbook oncological outcomes and overall survival in non-small cell lung cancer.
Read More
Lymphovascular Invasion May Be a Key Predictor for Postoperative Recurrence of NSCLC
Lymphovascular invasion is an independent predictor for shorter recurrence-free survival for patients with stage I NSCLC.
Read More
Q&A: The Need to Evaluate & Manage Insomnia in Patients With Alzheimer’s Disease
Research finds a significant association between diagnosed insomnia and increased prevalence of behavioral symptoms in patients with Alzheimer’s Disease.
Read More
How Struggling Hospital Operating Margins & Rising Patient Volume Affect Physicians
Although patient volume is rising in healthcare systems, costs that outpace gains up to 3:1 continue to squeeze margins.
Read More
Improved Histiocytic Neoplasm Treatments & Life Expectancy Bring QOL Challenges
Thanks to new treatments, more people survive histiocytic neoplasms, but their survival comes with challenges, according to findings published in Blood.
Read More
RSV Risk in Toddlers Suggests Need to Expand Prevention Efforts
Various factors impact the risk for subsequent respiratory conditions among children with RSV before age 2, including prematurity and socioeconomic status.
Read More
Treat Yourself During Crohn’s & Colitis Congress
All work and no play? No way! Fun is at your fingertips during your Crohn’s & Colitis Congress stay at the Bellagio!
Read More
Live Stream Crohn’s & Colitis Congress Satellite Symposia
Learn and earn credits through live-streamed satellite symposia during the Crohn’s & Colitis...
Read More
Meet, Mix & Mingle at Crohn’s & Colitis Congress Social Events
Make time to meet, mix and mingle at these Crohn’s & Colitis Congress social events!
Read More
Transplant May Be Appropriate for Wider Range of Liver Neoplasms
Recent research suggests liver transplant may benefit patients with an expanding range of primary or secondary hepatic malignancies.
Read More
Unhealthy View on Vegetables
“My mother told me to always listen to my heart.”
Read More
Patient Perception of MS Symptoms Influences Functional Activity Difficulty
Study determines that the way patients with MS perceive their symptoms affects how difficult they report the ability to complete functional activities.
Read More
Don’t Miss Psoriasis Update: 2024 at Maui Derm Hawaii
Whether you’re headed to Maui Derm Hawaii 2024, January 22-26, 2024, in Maui, Hawaii, or attending the conference virtually, don’t miss Psoriasis Update: 2024!
Read More
Extrapyramidal Rating Scale Effectively Measures Tardive Dyskinesia Symptoms
The Extrapyramidal Symptom Rating Scale and an abbreviated version of the scale were both validated for measuring the impact of tardive dyskinesia.
Read More